Loading: 100%
BRISTOL MYERS SQUIBB CO logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter New York, United States of AmericaNew York, United States of Americano data available
Employees 25,000 (as per Q1 2017)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker BMYno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 174048566472
datesClosing price (adj.)
13.10.201765.29
11.10.201765.11
04.10.201764.35
27.09.201762.57
20.09.201763.10
13.09.201762.10
06.09.201759.51
30.08.201759.02
23.08.201757.52
16.08.201757.15
09.08.201757.05
02.08.201754.89
26.07.201755.64
19.07.201754.74
12.07.201754.71
05.07.201756.01
27.06.201755.18
20.06.201754.94
13.06.201753.49
06.06.201750.99
30.05.201753.23
23.05.201753.51
16.05.201753.69
09.05.201754.61
02.05.201755.23
25.04.201753.24
18.04.201752.25
11.04.201752.30
04.04.201753.05
28.03.201755.07
21.03.201754.59
14.03.201755.55
07.03.201755.20
28.02.201755.57
21.02.201753.68
14.02.201752.63
07.02.201750.62
31.01.201748.17
24.01.201747.98
17.01.201755.15
10.01.201758.77
03.01.201757.87
27.12.201657.76
19.12.201657.84
12.12.201655.05
05.12.201654.08
28.11.201655.01
21.11.201655.23
14.11.201655.06
07.11.201651.22
31.10.201649.56
24.10.201647.92
17.10.201648.03
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
65.29n/a
Market Capitalisation
in million USD
107,561n/a
Enterprise Value
in million USD
110,005n/a
Common Shares Outstanding
as per Mar 31, 2017
1,647,434,458n/a
Preferred Shares Outstanding
as per Mar 31, 2017
4,129n/a
Average Basic Shares Outstanding
TTM
1,669,250,000n/a
Average Diluted Shares Outstanding
TTM
1,677,750,000n/a
Index Membership
n/a
Business Summary
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.
no data available
Key Financials & Ratios (all figures TTM as per Mar 31, 2017, million USD, full statements further below)
Profit & Loss
Revenues 19,965n/a
Gross Profit 14,812n/a
Operating Income 4,803n/a
EBITDA 5,313n/a
Net Profit 4,836n/a
Balance Sheet
Cash and Cash Equivalents 6,109n/a
Receivables 0n/a
Total Current Assets 13,615n/a
PP&E 5,020n/a
Total Assets 32,937n/a
Accounts Payable 1,503n/a
Current Debt 1,197n/a
Total Current Liabilities 8,494n/a
Long-Term Debt 7,237n/a
Total Liabilities 18,402n/a
Total Equity 14,535n/a
Cash Flow
Depreciation & Amortisation 510n/a
Change in Working Capital -1,139n/a
Operating Cash Flow 3,939n/a
Net Change in PP&E and Intangibles -1,264n/a
Investing Cash Flow -149n/a
Dividends Paid -2,561n/a
Financing Cash Flow -2,508n/a
Total Change in Cash 1,266n/a
Free Cash Flow 1,522n/a
Profitability Ratios
Gross Margin 74.2%n/a
Operating Margin 24.1%n/a
Net Profit Margin 24.2%n/a
Return on Equity 33.2%n/a
Return on Assets 14.7%n/a
Per Share Figures
Basic EPS 2.90n/a
Diluted EPS 2.88n/a
Sales per Share 11.96n/a
Book Value per Share 8.64n/a
FCF per Share 0.91n/a
Dividends per Share 1.53n/a
Price Multiples
Price to Earnings Ratio 22.54n/a
Price to Sales Ratio 5.46n/a
Price to Book Value 7.50n/a
Price to Free Cash Flow 71.61n/a
Valuation Metrics
EV/EBITDA 20.70n/a
EV/Sales 5.51n/a
Book to Market Value 0.14n/a
Other Ratios
Current Ratio 160.3%n/a
Liabilities to Equity Ratio 126.6%n/a
Debt to Assets Ratio 25.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
15,617
17,715
18,808
19,484
21,244
17,621
16,385
15,879
16,560
19,427
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
0
Cost of revenue
-4,919
-5,316
-5,140
-5,277
-5,598
-4,610
-4,619
-3,932
-3,909
-4,946
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
10,698
12,399
13,668
14,207
15,646
13,011
11,766
11,947
12,651
14,481
Other Operating Income
0
0
0
0
0
0
0
0
0
0
Operating Expenses
-8,198
-8,833
-8,729
-8,229
-8,999
-8,921
-8,670
-9,356
-10,761
-9,851
Selling, General & Administrative
-5,038
-5,321
-5,082
-4,663
-5,160
-5,017
-4,939
-4,822
-4,841
-4,911
Selling & Marketing
0
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
0
Research & Development
-3,160
-3,512
-3,647
-3,566
-3,839
-3,904
-3,731
-4,534
-5,920
-4,940
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
2,500
3,566
4,939
5,978
6,647
4,090
3,096
2,591
1,890
4,630
Non-Operating Income (Loss)
447
595
931
93
334
80
-205
-210
187
1,285
Interest Expense, net
0
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
524
617
550
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-77
-22
381
93
334
80
-205
-210
187
1,285
Pretax Income (Loss), Adjusted
2,947
4,161
5,870
6,071
6,981
4,170
2,891
2,381
2,077
5,915
Abnormal Gains (Losses)
-424
615
-268
0
0
-1,830
0
0
0
0
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
2,523
4,776
5,602
6,071
6,981
2,340
2,891
2,381
2,077
5,915
Income Tax (Expense) Benefit, net
-471
-1,090
-1,182
-1,558
-1,721
161
-311
-352
-446
-1,408
Current Income Tax
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
2,052
3,686
4,420
4,513
5,260
2,501
2,580
2,029
1,631
4,507
Net Extraordinary Gains (Losses)
876
2,557
7,442
0
0
0
0
0
0
0
Discontinued Operations
876
2,557
7,442
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
2,928
6,243
11,862
4,513
5,260
2,501
2,580
2,029
1,631
4,507
Minority Interest
-763
-996
-1,250
-1,411
-1,551
-541
-17
-25
-66
-50
Net Income
2,165
5,247
10,612
3,102
3,709
1,960
2,563
2,004
1,565
4,457
Preferred Dividends
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
2,165
5,247
10,612
3,102
3,709
1,960
2,563
2,004
1,565
4,457
Remarks
restated on Feb 19, 2010 n/a
calculated values,
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 17, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 14, 2014 n/a
calculated values,
restated on Feb 13, 2015 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
Balance SheetBS data quality: 99% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
8,265
8,514
7,301
8,733
2,829
4,525
7,435
4,270
6,350
Cash & Cash Equivalents
n/a
7,976
7,683
5,033
5,776
1,656
3,586
5,571
2,385
4,237
Short Term Investments
n/a
289
831
2,268
2,957
1,173
939
1,864
1,885
2,113
Accounts & Notes Receivable
n/a
3,644
3,164
3,480
3,743
3,083
3,360
3,390
4,299
5,543
Accounts Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
0
Inventories
n/a
1,765
1,413
1,204
1,384
1,657
1,498
1,560
1,221
1,241
Raw Materials
n/a
0
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
1,023
867
1,288
1,458
1,952
9,533
2,223
625
570
Prepaid Expenses
n/a
320
256
252
258
355
412
470
625
570
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
7,420
109
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
703
611
1,036
1,200
1,597
1,701
1,644
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
0
Total Current Assets
n/a
14,697
13,958
13,273
15,318
9,521
18,916
14,608
10,415
13,704
Property, Plant & Equipment, Net
n/a
5,405
5,055
4,664
4,521
5,333
4,579
4,417
4,412
4,980
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
188
1,369
2,681
2,909
3,523
3,747
4,408
4,660
2,719
Long Term Investments
n/a
0
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
188
1,369
2,681
2,909
3,523
3,747
4,408
4,660
2,719
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
9,196
10,626
10,458
10,222
17,520
11,350
10,316
12,261
12,304
Intangible Assets
n/a
0
0
0
0
0
0
0
0
0
Goodwill
n/a
4,827
5,218
5,233
5,586
7,635
7,096
7,027
6,881
6,875
Other Intangible Assets
n/a
1,151
2,865
3,370
3,124
8,778
2,318
1,753
1,419
1,385
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
2,137
1,636
850
688
203
508
915
2,844
2,996
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
1,081
907
1,005
824
904
1,428
621
1,117
1,048
Total Noncurrent Assets
n/a
14,789
17,050
17,803
17,652
26,376
19,676
19,141
21,333
20,003
Total Assets
n/a
29,486
31,008
31,076
32,970
35,897
38,592
33,749
31,748
33,707
Liabilities and owners' equity
Payables & Accruals
n/a
6,279 6279000000
5,845 5845000000
6,220 6220000000
7,328 7328000000
6,628 6628000000
6,394 6394000000
6,704 6704000000
6,875 6875000000
7,087 7087000000
Accounts Payable
n/a
1,535 1535000000
1,711 1711000000
1,983 1983000000
2,603 2603000000
2,202 2202000000
2,559 2559000000
2,487 2487000000
1,565 1565000000
1,664 1664000000
Accrued Taxes
n/a
347 347000000
175 175000000
65 65000000
167 167000000
193 193000000
160 160000000
262 262000000
572 572000000
152 152000000
Interest & Dividends Payable
n/a
617 617000000
552 552000000
575 575000000
597 597000000
606 606000000
634 634000000
645 645000000
0 0
0 0
Other Payables & Accruals
n/a
3,780 3780000000
3,407 3407000000
3,597 3597000000
3,961 3961000000
3,627 3627000000
3,041 3041000000
3,310 3310000000
4,738 4738000000
5,271 5271000000
Short Term Debt
n/a
154 154000000
231 231000000
117 117000000
115 115000000
826 826000000
359 359000000
590 590000000
139 139000000
992 992000000
Short Term Borrowings
n/a
154 154000000
231 231000000
117 117000000
115 115000000
826 826000000
359 359000000
590 590000000
139 139000000
992 992000000
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
277 277000000
237 237000000
402 402000000
337 337000000
825 825000000
5,687 5687000000
1,167 1167000000
1,003 1003000000
762 762000000
Deferred Revenue
n/a
277 277000000
237 237000000
402 402000000
337 337000000
825 825000000
756 756000000
1,167 1167000000
1,003 1003000000
762 762000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
4,931 4931000000
0 0
0 0
0 0
Total Current Liabilities
n/a
6,710 6710000000
6,313 6313000000
6,739 6739000000
7,780 7780000000
8,279 8279000000
12,440 12440000000
8,461 8461000000
8,017 8017000000
8,841 8841000000
Long Term Debt
n/a
6,585 6585000000
6,130 6130000000
5,328 5328000000
5,376 5376000000
6,568 6568000000
7,981 7981000000
7,242 7242000000
6,550 6550000000
5,716 5716000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
3,983 3983000000
3,780 3780000000
3,371 3371000000
3,947 3947000000
7,412 7412000000
2,935 2935000000
3,063 3063000000
2,757 2757000000
2,803 2803000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
2,285 2285000000
1,658 1658000000
1,297 1297000000
2,017 2017000000
1,882 1882000000
718 718000000
1,115 1115000000
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
791 791000000
949 949000000
895 895000000
866 866000000
4,024 4024000000
769 769000000
770 770000000
586 586000000
547 547000000
Deferred Tax Liabilities
n/a
466 466000000
751 751000000
755 755000000
680 680000000
1,031 1031000000
823 823000000
560 560000000
742 742000000
973 973000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
441 441000000
422 422000000
424 424000000
384 384000000
475 475000000
625 625000000
618 618000000
1,429 1429000000
1,283 1283000000
Total Noncurrent Liabilities
n/a
10,568 10568000000
9,910 9910000000
8,699 8699000000
9,323 9323000000
13,980 13980000000
10,916 10916000000
10,305 10305000000
9,307 9307000000
8,519 8519000000
Total Liabilities
n/a
17,278 17278000000
16,223 16223000000
15,438 15438000000
17,103 17103000000
22,259 22259000000
23,356 23356000000
18,766 18766000000
17,324 17324000000
17,360 17360000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
2,977 2977000000
3,988 3988000000
3,902 3902000000
3,334 3334000000
2,915 2915000000
2,143 2143000000
1,728 1728000000
1,680 1680000000
1,946 1946000000
Common Stock
n/a
220 220000000
220 220000000
220 220000000
220 220000000
221 221000000
221 221000000
221 221000000
221 221000000
221 221000000
Additional Paid in Capital
n/a
2,757 2757000000
3,768 3768000000
3,682 3682000000
3,114 3114000000
2,694 2694000000
1,922 1922000000
1,507 1507000000
1,459 1459000000
1,725 1725000000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-10,566 -10566000000
-17,364 -17364000000
-17,454 -17454000000
-17,402 -17402000000
-18,823 -18823000000
-17,800 -17800000000
-16,992 -16992000000
-16,559 -16559000000
-16,779 -16779000000
Retained Earnings
n/a
22,549 22549000000
30,760 30760000000
31,636 31636000000
33,069 33069000000
32,733 32733000000
32,952 32952000000
32,541 32541000000
31,613 31613000000
33,513 33513000000
Other Equity
n/a
-2,719 -2719000000
-2,541 -2541000000
-2,371 -2371000000
-3,045 -3045000000
-3,202 -3202000000
-2,141 -2141000000
-2,425 -2425000000
-2,468 -2468000000
-2,503 -2503000000
Equity Before Minority Interest
n/a
12,241 12241000000
14,843 14843000000
15,713 15713000000
15,956 15956000000
13,623 13623000000
15,154 15154000000
14,852 14852000000
14,266 14266000000
16,177 16177000000
Minority Interest
n/a
-33 -33000000
58 58000000
-75 -75000000
-89 -89000000
15 15000000
82 82000000
131 131000000
158 158000000
170 170000000
Total Equity
n/a
12,208 12208000000
14,901 14901000000
15,638 15638000000
15,867 15867000000
13,638 13638000000
15,236 15236000000
14,983 14983000000
14,424 14424000000
16,347 16347000000
Total Liabilities & Equity
n/a
29,486 29486000000
31,124 31124000000
31,076 31076000000
32,970 32970000000
35,897 35897000000
38,592 38592000000
33,749 33749000000
31,748 31748000000
33,707 33707000000
Remarks restated on n/a restated on Feb 19, 2010 n/a restated on Feb 18, 2011 n/a restated on Feb 17, 2012 n/a restated on Feb 15, 2013 n/a restated on Feb 14, 2014 n/a restated on Feb 13, 2015 n/a restated on Feb 12, 2016 n/a restated on Feb 21, 2017 n/a restated on Apr 27, 2017 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
2,165
5,247
10,612
3,102
3,709
1,960
2,563
2,029
1,631
4,507
Net Income
0
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
892
816
707
607
628
681
763
467
376
382
Non-Cash Items
103
-2,473
-7,296
811
457
4,931
25
410
833
-679
Stock-Based Compensation
133
181
183
193
161
154
191
213
235
205
Deferred Income Taxes
-416
1,430
163
422
415
-1,230
-491
-542
-347
-204
Other Non-Cash Adjustments
386
-4,084
-7,642
196
-119
6,007
325
739
945
-680
Change in Working Capital
-7
117
42
-29
46
-631
194
242
-1,008
-1,360
(Increase) Decrease in Accounts Receivable
-458
-360
227
-270
-220
648
-504
-252
-942
-803
(Increase) Decrease in Inventories
-54
130
82
156
-193
-103
-45
-254
97
-152
Increase (Decrease) in Accounts Payable
141
253
472
315
593
-232
412
-44
-919
104
Increase (Decrease) in Other
364
94
-739
-230
-134
-944
331
792
756
-509
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
3,153
3,707
4,065
4,491
4,840
6,941
3,545
3,148
1,832
2,850
Change in Fixed Assets & Intangibles
-843
-714
-730
-424
-367
-548
-537
-526
-820
-1,215
Disposition of Fixed Assets & Intangibles
0
227
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
227
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
-843
-941
-730
-424
-367
-548
-537
-526
-820
-1,215
Net Change in Long Term Investment
756
138
-1,414
-2,626
-859
1,283
-44
-1,624
-349
1,720
Decrease in Long Term Investment
20,634
560
2,075
3,197
5,960
4,890
1,815
4,095
2,794
4,809
Increase in Long Term Investment
-19,878
-422
-3,489
-5,823
-6,819
-3,607
-1,859
-5,719
-3,143
-3,089
Net Cash From Acquisitions & Divestitures
0
1,007
0
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
0
Other Investing Activities
-115
118
-2,236
-762
-211
-7,462
9
3,366
-403
975
Net Cash From Discontinued Operations (investing)
0
4,530
0
0
0
0
0
0
0
0
Cash from Investing Activities
-202
5,079
-4,380
-3,812
-1,437
-6,727
-572
1,216
-1,572
1,480
Dividends Paid
-2,213
-2,461
-2,483
-2,202
-2,254
-2,286
-2,309
-2,398
-2,477
-2,547
Cash From (Repayment of) Debt
-1,333
-337
1,445
-963
-79
-109
1,090
-432
-1,138
110
Cash From (Repayment of) Short Term Debt, net
-33
-1,688
-26
-33
-1
49
198
244
-449
125
Cash From (Repayment of) Long Term Debt, net
-1,300
1,351
1,471
-930
-78
-158
892
-676
-689
-15
Repayments of Long Term Debt
-1,300
-229
-212
-936
-78
-2,108
-597
-676
-1,957
-15
Cash From Long Term Debt
0
1,580
1,683
6
0
1,950
1,489
0
1,268
0
Cash From (Repurchase of) Equity
333
5
45
-324
-620
-1,940
131
288
266
-50
Increase in Capital Stock
333
5
45
252
601
463
564
288
266
181
Decrease in Capital Stock
0
0
0
-576
-1,221
-2,403
-433
0
0
-231
Other Financing Activities
0
211
976
146
296
2
20
105
-2
42
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-3,213
-2,582
-17
-3,343
-2,657
-4,333
-1,068
-2,437
-3,351
-2,445
Net Cash Before Disc. Operations and FX
-262
6,204
-332
-2,664
746
-4,119
1,905
1,927
-3,091
1,885
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-262
6,204
-332
-2,664
746
-4,119
1,905
1,927
-3,091
1,885
Effect of Foreign Exchange Rates
45
-29
39
14
-3
-1
25
58
-95
-33
Net Changes in Cash
-217
6,175
-293
-2,650
743
-4,120
1,930
1,985
-3,186
1,852
Remarks
restated on Feb 19, 2010 n/a
calculated values,
restated on Feb 18, 2011 n/a
calculated values,
restated on Feb 17, 2012 n/a
calculated values,
restated on Feb 15, 2013 n/a
calculated values,
restated on Feb 14, 2014 n/a
calculated values,
restated on Feb 13, 2015 n/a
calculated values,
restated on Feb 12, 2016 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
restated on Feb 21, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo